Long Haul Lyme Disease Risk Found: Even in Early Treated Patients | Johns Hopkins Rheumatology

Written by Global Lyme Alliance | Apr 6, 2022 7:49:40 PM

John Aucott, MD, Director of the Johns Hopkins Medicine Lyme Disease Research Center, discusses his team’s study that finds significant risk of functionally impairing persistent symptoms after early diagnosis and treatment of acute Lyme disease.

This study is significant as, "14% of early treated Lyme disease patients suffered quality of life impairing persistent symptoms when examined 6 to 12 months later. Fatigue, pain and cognitive symptoms persisted despite early diagnosis and prompt treatment." It's important to bring attention to those experiencing long-haul Lyme disease and continue searching for answers, as well as an effective treatment.